Literature DB >> 28159418

The role of p62/SQSTM1 in sporadic inclusion body myositis.

Satoshi Nakano1, Mitsuaki Oki2, Hirofumi Kusaka2.   

Abstract

We examined selective autophagy against ubiquitinated protein aggregates in sporadic inclusion body myositis (s-IBM) patients. The form of autophagy requires phosphorylation of serine 403 in p62/SQSTM1 to bind to Lys63-linked ubiquitin and the binding of the p62-ubiquitinated protein conjugates to LC3. In muscle biopsy specimens from 16 s-IBM patients, we compared the distribution of p62 (aa120-440) with 1) Ser403-phosphorylated p62 (S403-pp62), 2) Lys63-linked ubiquitin and 3) LC3 in double-colour immunofluorescence microscopy. S403-pp62, Lys63-linked ubiquitin and LC3 colocalised with p62 aggregates, 79.05% ± 13.64% (mean ± SD), 66.54% ± 19.91% and 51.84% ± 14.1%, respectively. Although positive deposits of S403-pp62 and Lys63-linked ubiquitin were always observed within p62 aggregates, LC3 often showed dissociated distribution from p62. We also found fibres containing small, numerous p62-positive dots that were negative for all three markers and were also observed in myositis controls. The results indicate that p62, Lys63-linked ubiquitin and LC3 in s-IBM join to perform selective autophagy. p62 could be induced by some cellular stresses in all types of myositis; however, in s-IBM, compromised binding of the p62-ubiquitinated protein complex to LC3 could stop the autophagy process in its initial stages, which causes the formation of aggregates of p62-oligomers with Lys63-ubiquitinated proteins.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  LC3; Lys63-linked ubiquitin; Selective autophagy; Sporadic inclusion body myositis (s-IBM); p62/SQSTM1

Mesh:

Substances:

Year:  2016        PMID: 28159418     DOI: 10.1016/j.nmd.2016.12.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

Review 1.  Inclusion Body Myositis: Update on Pathogenesis and Treatment.

Authors:  Elie Naddaf; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 2.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

Review 3.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

Review 4.  The Role of Autophagy in Skeletal Muscle Diseases.

Authors:  Qianghua Xia; Xubo Huang; Jieru Huang; Yongfeng Zheng; Michael E March; Jin Li; Yongjie Wei
Journal:  Front Physiol       Date:  2021-03-25       Impact factor: 4.566

Review 5.  Programmed Cell Death Pathways in the Pathogenesis of Idiopathic Inflammatory Myopathies.

Authors:  Jia Shi; Mingwei Tang; Shuang Zhou; Dong Xu; Jiuliang Zhao; Chanyuan Wu; Qian Wang; Xinping Tian; Mengtao Li; Xiaofeng Zeng
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

6.  Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies.

Authors:  Jose C Milisenda; Iago Pinal-Fernandez; Thomas E Lloyd; Josep María Grau; Frederick W Miller; Albert Selva-O'Callaghan; Lisa Christopher-Stine; Werner Stenzel; Andrew L Mammen; Andrea M Corse
Journal:  Clin Exp Rheumatol       Date:  2020-09-01       Impact factor: 4.862

7.  Feeder-supported in vitro exercise model using human satellite cells from patients with sporadic inclusion body myositis.

Authors:  Yuqing Li; Weijian Chen; Kazumi Ogawa; Masashi Koide; Tadahisa Takahashi; Yoshihiro Hagiwara; Eiji Itoi; Toshimi Aizawa; Masahiro Tsuchiya; Rumiko Izumi; Naoki Suzuki; Masashi Aoki; Makoto Kanzaki
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.